BioRestorative Therapies
BRTX
11 hedge funds and large institutions have $649K invested in BioRestorative Therapies in 2023 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 3 closing their positions.
0.52% less ownership
Funds ownership: 8.29% → 7.77% (-0.52%)
8% less funds holding
Funds holding: 12 → 11 (-1)
25% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 4
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
54% less capital invested
Capital invested by funds: $1.42M → $649K (-$774K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LCM
Lynwood Capital Management
Toronto,
Ontario, Canada
|
+$50.4K |
| 2 |
FIA
FNY Investment Advisers
New York
|
+$37K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$27.4K |
| 4 |
SG
StoneX Group
New York
|
+$22.7K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
+$756 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WA
Wealth Alliance
Mellville,
New York
|
-$10.9K |
| 2 |
SPIA
Steward Partners Investment Advisory
New York
|
-$8.82K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$7.77K |
| 4 |
Wells Fargo
San Francisco,
California
|
-$5.6K |
| 5 |
Two Sigma Advisers
New York
|
-$4.29K |
BRTX Hedge Fund Activity: Q3 2023 in Review
11 of the 6,311 institutional investors tracked by Wall St. Rank reported a position in BioRestorative Therapies (BRTX) for Q3 2023, worth a combined $649K — down 54% from $1.42M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of BRTX and 2 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 3 added.
The largest buyer was Lynwood Capital Management, opening a new position worth an estimated $50.4K. The largest seller was Wealth Alliance, cutting an estimated $10.9K.
- 11 institutional investors held BioRestorative Therapies (BRTX) as of Q3 2023, down from 12 in Q2 2023.
- Funds reported $649K of BioRestorative Therapies stock for Q3 2023, down 54% quarter-over-quarter.
- 2 funds opened new BioRestorative Therapies positions in Q3 2023 and 3 closed out, a net change of -1 holder.
- The largest BioRestorative Therapies buyer in Q3 2023 was Lynwood Capital Management, an estimated $50.4K added.
- The largest BioRestorative Therapies seller in Q3 2023 was Wealth Alliance, an estimated $10.9K sold.
Based on aggregated 13F filings for Q3 2023.